Phase 1/2 Trial of AT-101 in Combination With Lenalidomide and Dexamethasone in Patients With Relapsed Symptomatic Multiple Myeloma
Phase of Trial: Phase I/II
Latest Information Update: 01 Feb 2018
At a glance
- Drugs AT 101 (Primary) ; Dexamethasone; Lenalidomide
- Indications Multiple myeloma
- Focus Adverse reactions; Therapeutic Use
- 26 Jan 2018 Status changed from recruiting to suspended.
- 10 Jun 2017 Biomarkers information updated
- 08 May 2017 Planned number of patients changed from 69 to 63.